PEGylated long-circulating liposomes deliver homoharringtonine to suppress multiple myeloma cancer stem cells

Reinforcing B16F10/GPI-IL-21 vaccine efficacy against melanoma by injecting mice with shZEB1 plasmid or miR200c agomir

(2016) Xiaoying Wang et al.   BIOMEDICINE & PHARMACOTHERAPY

Sorafenib for the treatment of multiple myeloma

(2016) Massimo Gentile et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

FDA approves three different multiple myeloma drugs in one month

(2016) Mark Ratner   NATURE BIOTECHNOLOGY

Novel drug delivery liposomes targeted with a fully human anti-VEGF165 monoclonal antibody show superior antitumor efficacy in vivo

(2015) Chenyang Shi et al.   BIOMEDICINE & PHARMACOTHERAPY

Metabolic Signature Identifies Novel Targets for Drug Resistance in Multiple Myeloma

(2015) P. Maiso et al.   CANCER RESEARCH

Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis

(2015) Stephan Philipp et al.   Cell Communication and Signaling

Homoharringtonine increases intestinal epithelial permeability by modulating specific claudin isoforms in Caco-2 cell monolayers

(2015) Akihiro Watari et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Inhibitory effect of epirubicin-loaded lipid microbubbles with conjugated anti-ABCG2 antibody combined with therapeutic ultrasound on multiple myeloma cancer stem cells

(2015) Fangfang Shi et al.   JOURNAL OF DRUG TARGETING

Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectives

(2015) S Lonial et al.   LEUKEMIA

Target therapy of multiple myeloma by PTX-NPs and ABCG2 antibody in a mouse xenograft model

(2015) Cuiping Yang et al.   Oncotarget

Omacetaxine mepesuccinate in chronic myeloid leukemia

(2014) Omar Al Ustwani et al.   EXPERT OPINION ON PHARMACOTHERAPY

Concise Review: Defining and Targeting Myeloma Stem Cell-Like Cells

(2014) Masahiro Abe et al.   STEM CELLS

γ-Fe2O3 Nanoparticles Increase Therapeutic Efficacy of Combination with Paclitaxel and Anti-ABCG2 Monoclonal Antibody on Multiple Myeloma Cancer Stem Cells in Mouse Model

(2013) Cuiping Yang et al.   Journal of Biomedical Nanotechnology

Targeted therapeutic effect of anti-ABCG2 antibody combined with nano silver and vincristine on mouse myeloma cancer stem cells

(2013) Jun Dou et al.   JOURNAL OF NANOPARTICLE RESEARCH

Anti-ABCG2 monoclonal antibody in combination with paclitaxel nanoparticles against cancer stem-like cell activity in multiple myeloma

(2013) Cuiping Yang et al.   Nanomedicine

Reovirus as a Viable Therapeutic Option for the Treatment of Multiple Myeloma

(2012) C. M. Thirukkumaran et al.   CLINICAL CANCER RESEARCH

Role of Interleukin 16 in Multiple Myeloma

(2012) D. Atanackovic et al.   JNCI-Journal of the National Cancer Institute

Can we change the disease biology of multiple myeloma?

(2012) Ivan Borrello   LEUKEMIA RESEARCH

Autophagy protects breast cancer cells from epirubicin-induced apoptosis and facilitates epirubicin-resistance development

(2011) Wei-Liang Sun et al.   Autophagy

Animal models: Towards a myeloma mouse

(2011) Sarah DeWeerdt   NATURE

Perspective: A model disease

(2011) William Matsui   NATURE

Cytotoxicity and Genotoxicity of Silver Nanoparticles in Human Cells

(2008) P. V. AshaRani et al.   ACS Nano

Ultrasound Imaging of Renal Vaso-Occlusive Events in Transgenic Sickle Mice Exposed to Hypoxic Stress

(2008) Philippe Bonnin et al.   ULTRASOUND IN MEDICINE AND BIOLOGY